nodes	percent_of_prediction	percent_of_DWPC	metapath
Cladribine—ABCG2—Omeprazole—Barrett's esophagus	0.441	1	CbGbCtD
Cladribine—Pain of skin—Esomeprazole—Barrett's esophagus	0.0183	0.0408	CcSEcCtD
Cladribine—Pain of skin—Omeprazole—Barrett's esophagus	0.0183	0.0408	CcSEcCtD
Cladribine—NR5A1—Nuclear Receptors—NR1I2—Barrett's esophagus	0.00821	0.107	CbGpPWpGaD
Cladribine—Polyp—Esomeprazole—Barrett's esophagus	0.00708	0.0158	CcSEcCtD
Cladribine—Polyp—Omeprazole—Barrett's esophagus	0.00708	0.0158	CcSEcCtD
Cladribine—NR5A1—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.00649	0.0845	CbGpPWpGaD
Cladribine—Cyst—Omeprazole—Barrett's esophagus	0.00644	0.0144	CcSEcCtD
Cladribine—Cyst—Esomeprazole—Barrett's esophagus	0.00644	0.0144	CcSEcCtD
Cladribine—PNP—digestive system—Barrett's esophagus	0.00602	0.174	CbGeAlD
Cladribine—Rash erythematous—Omeprazole—Barrett's esophagus	0.00562	0.0125	CcSEcCtD
Cladribine—Rash erythematous—Esomeprazole—Barrett's esophagus	0.00562	0.0125	CcSEcCtD
Cladribine—Fungal infection—Esomeprazole—Barrett's esophagus	0.00558	0.0124	CcSEcCtD
Cladribine—Fungal infection—Omeprazole—Barrett's esophagus	0.00558	0.0124	CcSEcCtD
Cladribine—POLE3—digestive system—Barrett's esophagus	0.00528	0.153	CbGeAlD
Cladribine—Petechiae—Esomeprazole—Barrett's esophagus	0.00523	0.0117	CcSEcCtD
Cladribine—Petechiae—Omeprazole—Barrett's esophagus	0.00523	0.0117	CcSEcCtD
Cladribine—SLC28A3—digestive system—Barrett's esophagus	0.00495	0.143	CbGeAlD
Cladribine—RRM2B—Direct p53 effectors—MCL1—Barrett's esophagus	0.00491	0.0639	CbGpPWpGaD
Cladribine—Bone disorder—Omeprazole—Barrett's esophagus	0.00477	0.0106	CcSEcCtD
Cladribine—Bone disorder—Esomeprazole—Barrett's esophagus	0.00477	0.0106	CcSEcCtD
Cladribine—Hyperuricaemia—Esomeprazole—Barrett's esophagus	0.00464	0.0104	CcSEcCtD
Cladribine—Hyperuricaemia—Omeprazole—Barrett's esophagus	0.00464	0.0104	CcSEcCtD
Cladribine—Blood uric acid increased—Omeprazole—Barrett's esophagus	0.00438	0.00979	CcSEcCtD
Cladribine—Blood uric acid increased—Esomeprazole—Barrett's esophagus	0.00438	0.00979	CcSEcCtD
Cladribine—Injection site reaction—Esomeprazole—Barrett's esophagus	0.00428	0.00955	CcSEcCtD
Cladribine—Injection site reaction—Omeprazole—Barrett's esophagus	0.00428	0.00955	CcSEcCtD
Cladribine—RRM1—E2F transcription factor network—MCL1—Barrett's esophagus	0.00412	0.0536	CbGpPWpGaD
Cladribine—Candida infection—Omeprazole—Barrett's esophagus	0.00411	0.00917	CcSEcCtD
Cladribine—Candida infection—Esomeprazole—Barrett's esophagus	0.00411	0.00917	CcSEcCtD
Cladribine—POLE—digestive system—Barrett's esophagus	0.00403	0.117	CbGeAlD
Cladribine—Neoplasm—Esomeprazole—Barrett's esophagus	0.00389	0.00869	CcSEcCtD
Cladribine—Neoplasm—Omeprazole—Barrett's esophagus	0.00389	0.00869	CcSEcCtD
Cladribine—Swelling—Esomeprazole—Barrett's esophagus	0.00354	0.00791	CcSEcCtD
Cladribine—Swelling—Omeprazole—Barrett's esophagus	0.00354	0.00791	CcSEcCtD
Cladribine—Vascular purpura—Omeprazole—Barrett's esophagus	0.00349	0.0078	CcSEcCtD
Cladribine—Vascular purpura—Esomeprazole—Barrett's esophagus	0.00349	0.0078	CcSEcCtD
Cladribine—RRM1—smooth muscle tissue—Barrett's esophagus	0.00349	0.101	CbGeAlD
Cladribine—Hepatic failure—Esomeprazole—Barrett's esophagus	0.00348	0.00776	CcSEcCtD
Cladribine—Hepatic failure—Omeprazole—Barrett's esophagus	0.00348	0.00776	CcSEcCtD
Cladribine—Haemolytic anaemia—Omeprazole—Barrett's esophagus	0.00346	0.00773	CcSEcCtD
Cladribine—Haemolytic anaemia—Esomeprazole—Barrett's esophagus	0.00346	0.00773	CcSEcCtD
Cladribine—RRM2—E2F transcription factor network—MCL1—Barrett's esophagus	0.00339	0.0441	CbGpPWpGaD
Cladribine—RRM2—digestive system—Barrett's esophagus	0.00332	0.096	CbGeAlD
Cladribine—Renal impairment—Omeprazole—Barrett's esophagus	0.00328	0.00733	CcSEcCtD
Cladribine—Renal impairment—Esomeprazole—Barrett's esophagus	0.00328	0.00733	CcSEcCtD
Cladribine—Purpura—Esomeprazole—Barrett's esophagus	0.00324	0.00724	CcSEcCtD
Cladribine—Purpura—Omeprazole—Barrett's esophagus	0.00324	0.00724	CcSEcCtD
Cladribine—Arthritis—Omeprazole—Barrett's esophagus	0.00322	0.00718	CcSEcCtD
Cladribine—Arthritis—Esomeprazole—Barrett's esophagus	0.00322	0.00718	CcSEcCtD
Cladribine—Pain in extremity—Omeprazole—Barrett's esophagus	0.00313	0.00698	CcSEcCtD
Cladribine—Pain in extremity—Esomeprazole—Barrett's esophagus	0.00313	0.00698	CcSEcCtD
Cladribine—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.00281	0.00628	CcSEcCtD
Cladribine—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.00281	0.00628	CcSEcCtD
Cladribine—RRM1—digestive system—Barrett's esophagus	0.00276	0.0797	CbGeAlD
Cladribine—Muscular weakness—Esomeprazole—Barrett's esophagus	0.00276	0.00615	CcSEcCtD
Cladribine—Muscular weakness—Omeprazole—Barrett's esophagus	0.00276	0.00615	CcSEcCtD
Cladribine—NR5A1—Nuclear Receptors—PPARG—Barrett's esophagus	0.0027	0.0352	CbGpPWpGaD
Cladribine—Sweating increased—Omeprazole—Barrett's esophagus	0.00263	0.00587	CcSEcCtD
Cladribine—Sweating increased—Esomeprazole—Barrett's esophagus	0.00263	0.00587	CcSEcCtD
Cladribine—SLC22A2—digestive system—Barrett's esophagus	0.00259	0.0748	CbGeAlD
Cladribine—Pancytopenia—Omeprazole—Barrett's esophagus	0.00257	0.00573	CcSEcCtD
Cladribine—Pancytopenia—Esomeprazole—Barrett's esophagus	0.00257	0.00573	CcSEcCtD
Cladribine—Neutropenia—Esomeprazole—Barrett's esophagus	0.00253	0.00564	CcSEcCtD
Cladribine—Neutropenia—Omeprazole—Barrett's esophagus	0.00253	0.00564	CcSEcCtD
Cladribine—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.00251	0.0056	CcSEcCtD
Cladribine—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.00251	0.0056	CcSEcCtD
Cladribine—Infestation NOS—Omeprazole—Barrett's esophagus	0.00241	0.00538	CcSEcCtD
Cladribine—Infestation—Omeprazole—Barrett's esophagus	0.00241	0.00538	CcSEcCtD
Cladribine—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00241	0.00538	CcSEcCtD
Cladribine—Infestation—Esomeprazole—Barrett's esophagus	0.00241	0.00538	CcSEcCtD
Cladribine—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.00239	0.00533	CcSEcCtD
Cladribine—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.00239	0.00533	CcSEcCtD
Cladribine—Renal failure—Omeprazole—Barrett's esophagus	0.00237	0.00528	CcSEcCtD
Cladribine—Renal failure—Esomeprazole—Barrett's esophagus	0.00237	0.00528	CcSEcCtD
Cladribine—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.00234	0.00523	CcSEcCtD
Cladribine—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.00234	0.00523	CcSEcCtD
Cladribine—Urinary tract infection—Omeprazole—Barrett's esophagus	0.00234	0.00523	CcSEcCtD
Cladribine—Conjunctivitis—Omeprazole—Barrett's esophagus	0.00234	0.00523	CcSEcCtD
Cladribine—POLA1—E2F transcription factor network—MCL1—Barrett's esophagus	0.00232	0.0302	CbGpPWpGaD
Cladribine—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.00228	0.00508	CcSEcCtD
Cladribine—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.00228	0.00508	CcSEcCtD
Cladribine—Epistaxis—Omeprazole—Barrett's esophagus	0.00227	0.00507	CcSEcCtD
Cladribine—Epistaxis—Esomeprazole—Barrett's esophagus	0.00227	0.00507	CcSEcCtD
Cladribine—Pharyngitis—Omeprazole—Barrett's esophagus	0.00215	0.00479	CcSEcCtD
Cladribine—Pharyngitis—Esomeprazole—Barrett's esophagus	0.00215	0.00479	CcSEcCtD
Cladribine—DCK—digestive system—Barrett's esophagus	0.00214	0.0619	CbGeAlD
Cladribine—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.00214	0.00477	CcSEcCtD
Cladribine—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.00214	0.00477	CcSEcCtD
Cladribine—NR5A1—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.00214	0.0278	CbGpPWpGaD
Cladribine—Oedema peripheral—Omeprazole—Barrett's esophagus	0.00213	0.00475	CcSEcCtD
Cladribine—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.00213	0.00475	CcSEcCtD
Cladribine—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.00212	0.00474	CcSEcCtD
Cladribine—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.00212	0.00474	CcSEcCtD
Cladribine—Urethral disorder—Omeprazole—Barrett's esophagus	0.00212	0.00473	CcSEcCtD
Cladribine—Urethral disorder—Esomeprazole—Barrett's esophagus	0.00212	0.00473	CcSEcCtD
Cladribine—RRM2B—Direct p53 effectors—HGF—Barrett's esophagus	0.00206	0.0269	CbGpPWpGaD
Cladribine—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.00204	0.00456	CcSEcCtD
Cladribine—Erythema multiforme—Omeprazole—Barrett's esophagus	0.00204	0.00456	CcSEcCtD
Cladribine—Eye disorder—Esomeprazole—Barrett's esophagus	0.00202	0.00451	CcSEcCtD
Cladribine—Eye disorder—Omeprazole—Barrett's esophagus	0.00202	0.00451	CcSEcCtD
Cladribine—Immune system disorder—Esomeprazole—Barrett's esophagus	0.00195	0.00436	CcSEcCtD
Cladribine—Immune system disorder—Omeprazole—Barrett's esophagus	0.00195	0.00436	CcSEcCtD
Cladribine—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00195	0.00435	CcSEcCtD
Cladribine—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00195	0.00435	CcSEcCtD
Cladribine—Chills—Omeprazole—Barrett's esophagus	0.00194	0.00433	CcSEcCtD
Cladribine—Chills—Esomeprazole—Barrett's esophagus	0.00194	0.00433	CcSEcCtD
Cladribine—Alopecia—Esomeprazole—Barrett's esophagus	0.00191	0.00426	CcSEcCtD
Cladribine—Alopecia—Omeprazole—Barrett's esophagus	0.00191	0.00426	CcSEcCtD
Cladribine—Mental disorder—Esomeprazole—Barrett's esophagus	0.00189	0.00423	CcSEcCtD
Cladribine—Mental disorder—Omeprazole—Barrett's esophagus	0.00189	0.00423	CcSEcCtD
Cladribine—Malnutrition—Esomeprazole—Barrett's esophagus	0.00188	0.0042	CcSEcCtD
Cladribine—Malnutrition—Omeprazole—Barrett's esophagus	0.00188	0.0042	CcSEcCtD
Cladribine—Flatulence—Omeprazole—Barrett's esophagus	0.00185	0.00414	CcSEcCtD
Cladribine—Flatulence—Esomeprazole—Barrett's esophagus	0.00185	0.00414	CcSEcCtD
Cladribine—Back pain—Omeprazole—Barrett's esophagus	0.00182	0.00406	CcSEcCtD
Cladribine—Back pain—Esomeprazole—Barrett's esophagus	0.00182	0.00406	CcSEcCtD
Cladribine—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.00175	0.0039	CcSEcCtD
Cladribine—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.00175	0.0039	CcSEcCtD
Cladribine—Anaemia—Omeprazole—Barrett's esophagus	0.00174	0.00388	CcSEcCtD
Cladribine—Anaemia—Esomeprazole—Barrett's esophagus	0.00174	0.00388	CcSEcCtD
Cladribine—Malaise—Esomeprazole—Barrett's esophagus	0.0017	0.00379	CcSEcCtD
Cladribine—Malaise—Omeprazole—Barrett's esophagus	0.0017	0.00379	CcSEcCtD
Cladribine—Cough—Esomeprazole—Barrett's esophagus	0.00164	0.00367	CcSEcCtD
Cladribine—Cough—Omeprazole—Barrett's esophagus	0.00164	0.00367	CcSEcCtD
Cladribine—Chest pain—Omeprazole—Barrett's esophagus	0.0016	0.00358	CcSEcCtD
Cladribine—Myalgia—Esomeprazole—Barrett's esophagus	0.0016	0.00358	CcSEcCtD
Cladribine—Arthralgia—Esomeprazole—Barrett's esophagus	0.0016	0.00358	CcSEcCtD
Cladribine—Chest pain—Esomeprazole—Barrett's esophagus	0.0016	0.00358	CcSEcCtD
Cladribine—Myalgia—Omeprazole—Barrett's esophagus	0.0016	0.00358	CcSEcCtD
Cladribine—Arthralgia—Omeprazole—Barrett's esophagus	0.0016	0.00358	CcSEcCtD
Cladribine—Anxiety—Omeprazole—Barrett's esophagus	0.0016	0.00356	CcSEcCtD
Cladribine—Anxiety—Esomeprazole—Barrett's esophagus	0.0016	0.00356	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00159	0.00355	CcSEcCtD
Cladribine—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00159	0.00355	CcSEcCtD
Cladribine—Discomfort—Esomeprazole—Barrett's esophagus	0.00158	0.00353	CcSEcCtD
Cladribine—Discomfort—Omeprazole—Barrett's esophagus	0.00158	0.00353	CcSEcCtD
Cladribine—Confusional state—Omeprazole—Barrett's esophagus	0.00155	0.00346	CcSEcCtD
Cladribine—Confusional state—Esomeprazole—Barrett's esophagus	0.00155	0.00346	CcSEcCtD
Cladribine—RRM2B—Direct p53 effectors—APC—Barrett's esophagus	0.00153	0.0199	CbGpPWpGaD
Cladribine—Infection—Esomeprazole—Barrett's esophagus	0.00153	0.00341	CcSEcCtD
Cladribine—Infection—Omeprazole—Barrett's esophagus	0.00153	0.00341	CcSEcCtD
Cladribine—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00151	0.00336	CcSEcCtD
Cladribine—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00151	0.00336	CcSEcCtD
Cladribine—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.0015	0.00336	CcSEcCtD
Cladribine—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.0015	0.00336	CcSEcCtD
Cladribine—Tachycardia—Omeprazole—Barrett's esophagus	0.0015	0.00335	CcSEcCtD
Cladribine—Tachycardia—Esomeprazole—Barrett's esophagus	0.0015	0.00335	CcSEcCtD
Cladribine—Skin disorder—Omeprazole—Barrett's esophagus	0.00149	0.00333	CcSEcCtD
Cladribine—Skin disorder—Esomeprazole—Barrett's esophagus	0.00149	0.00333	CcSEcCtD
Cladribine—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.00148	0.00331	CcSEcCtD
Cladribine—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.00148	0.00331	CcSEcCtD
Cladribine—ABCG2—Irinotecan Pathway—APC—Barrett's esophagus	0.00148	0.0193	CbGpPWpGaD
Cladribine—Anorexia—Esomeprazole—Barrett's esophagus	0.00146	0.00327	CcSEcCtD
Cladribine—Anorexia—Omeprazole—Barrett's esophagus	0.00146	0.00327	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.0014	0.00312	CcSEcCtD
Cladribine—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.0014	0.00312	CcSEcCtD
Cladribine—Insomnia—Omeprazole—Barrett's esophagus	0.00139	0.0031	CcSEcCtD
Cladribine—Insomnia—Esomeprazole—Barrett's esophagus	0.00139	0.0031	CcSEcCtD
Cladribine—Paraesthesia—Esomeprazole—Barrett's esophagus	0.00138	0.00308	CcSEcCtD
Cladribine—Paraesthesia—Omeprazole—Barrett's esophagus	0.00138	0.00308	CcSEcCtD
Cladribine—ABCG2—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.00137	0.0179	CbGpPWpGaD
Cladribine—Dyspnoea—Esomeprazole—Barrett's esophagus	0.00137	0.00306	CcSEcCtD
Cladribine—Dyspnoea—Omeprazole—Barrett's esophagus	0.00137	0.00306	CcSEcCtD
Cladribine—Somnolence—Omeprazole—Barrett's esophagus	0.00137	0.00305	CcSEcCtD
Cladribine—Somnolence—Esomeprazole—Barrett's esophagus	0.00137	0.00305	CcSEcCtD
Cladribine—POLE2—G1 to S cell cycle control—CDKN2A—Barrett's esophagus	0.00135	0.0176	CbGpPWpGaD
Cladribine—Decreased appetite—Esomeprazole—Barrett's esophagus	0.00134	0.00298	CcSEcCtD
Cladribine—Decreased appetite—Omeprazole—Barrett's esophagus	0.00134	0.00298	CcSEcCtD
Cladribine—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.00133	0.00296	CcSEcCtD
Cladribine—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.00133	0.00296	CcSEcCtD
Cladribine—Fatigue—Esomeprazole—Barrett's esophagus	0.00132	0.00296	CcSEcCtD
Cladribine—Fatigue—Omeprazole—Barrett's esophagus	0.00132	0.00296	CcSEcCtD
Cladribine—Pain—Omeprazole—Barrett's esophagus	0.00131	0.00293	CcSEcCtD
Cladribine—Pain—Esomeprazole—Barrett's esophagus	0.00131	0.00293	CcSEcCtD
Cladribine—Constipation—Esomeprazole—Barrett's esophagus	0.00131	0.00293	CcSEcCtD
Cladribine—Constipation—Omeprazole—Barrett's esophagus	0.00131	0.00293	CcSEcCtD
Cladribine—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.00127	0.00283	CcSEcCtD
Cladribine—Feeling abnormal—Omeprazole—Barrett's esophagus	0.00127	0.00283	CcSEcCtD
Cladribine—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.00126	0.0028	CcSEcCtD
Cladribine—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.00126	0.0028	CcSEcCtD
Cladribine—RRM2B—DNA Damage Response—TP53—Barrett's esophagus	0.00123	0.0161	CbGpPWpGaD
Cladribine—Urticaria—Esomeprazole—Barrett's esophagus	0.00122	0.00272	CcSEcCtD
Cladribine—Urticaria—Omeprazole—Barrett's esophagus	0.00122	0.00272	CcSEcCtD
Cladribine—Abdominal pain—Esomeprazole—Barrett's esophagus	0.00121	0.00271	CcSEcCtD
Cladribine—Body temperature increased—Esomeprazole—Barrett's esophagus	0.00121	0.00271	CcSEcCtD
Cladribine—Abdominal pain—Omeprazole—Barrett's esophagus	0.00121	0.00271	CcSEcCtD
Cladribine—Body temperature increased—Omeprazole—Barrett's esophagus	0.00121	0.00271	CcSEcCtD
Cladribine—SLC28A3—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.0012	0.0157	CbGpPWpGaD
Cladribine—RRM2B—miRNA Regulation of DNA Damage Response—TP53—Barrett's esophagus	0.00119	0.0155	CbGpPWpGaD
Cladribine—Hypersensitivity—Omeprazole—Barrett's esophagus	0.00113	0.00253	CcSEcCtD
Cladribine—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.00113	0.00253	CcSEcCtD
Cladribine—NR5A1—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.00112	0.0146	CbGpPWpGaD
Cladribine—Asthenia—Omeprazole—Barrett's esophagus	0.0011	0.00246	CcSEcCtD
Cladribine—Asthenia—Esomeprazole—Barrett's esophagus	0.0011	0.00246	CcSEcCtD
Cladribine—RRM1—Fluoropyrimidine Activity—TP53—Barrett's esophagus	0.00109	0.0143	CbGpPWpGaD
Cladribine—Pruritus—Esomeprazole—Barrett's esophagus	0.00109	0.00243	CcSEcCtD
Cladribine—Pruritus—Omeprazole—Barrett's esophagus	0.00109	0.00243	CcSEcCtD
Cladribine—Diarrhoea—Omeprazole—Barrett's esophagus	0.00105	0.00235	CcSEcCtD
Cladribine—Diarrhoea—Esomeprazole—Barrett's esophagus	0.00105	0.00235	CcSEcCtD
Cladribine—RRM1—E2F transcription factor network—CDKN2A—Barrett's esophagus	0.00104	0.0136	CbGpPWpGaD
Cladribine—Dizziness—Esomeprazole—Barrett's esophagus	0.00102	0.00227	CcSEcCtD
Cladribine—Dizziness—Omeprazole—Barrett's esophagus	0.00102	0.00227	CcSEcCtD
Cladribine—SLC28A3—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000999	0.013	CbGpPWpGaD
Cladribine—Vomiting—Esomeprazole—Barrett's esophagus	0.000977	0.00218	CcSEcCtD
Cladribine—Vomiting—Omeprazole—Barrett's esophagus	0.000977	0.00218	CcSEcCtD
Cladribine—Rash—Esomeprazole—Barrett's esophagus	0.000969	0.00216	CcSEcCtD
Cladribine—Rash—Omeprazole—Barrett's esophagus	0.000969	0.00216	CcSEcCtD
Cladribine—Dermatitis—Esomeprazole—Barrett's esophagus	0.000968	0.00216	CcSEcCtD
Cladribine—Dermatitis—Omeprazole—Barrett's esophagus	0.000968	0.00216	CcSEcCtD
Cladribine—Headache—Omeprazole—Barrett's esophagus	0.000962	0.00215	CcSEcCtD
Cladribine—Headache—Esomeprazole—Barrett's esophagus	0.000962	0.00215	CcSEcCtD
Cladribine—Nausea—Esomeprazole—Barrett's esophagus	0.000912	0.00204	CcSEcCtD
Cladribine—Nausea—Omeprazole—Barrett's esophagus	0.000912	0.00204	CcSEcCtD
Cladribine—RRM2—Fluoropyrimidine Activity—TP53—Barrett's esophagus	0.000901	0.0117	CbGpPWpGaD
Cladribine—POLE—G1 to S cell cycle control—CDKN2A—Barrett's esophagus	0.000872	0.0114	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—PTGES—Barrett's esophagus	0.000859	0.0112	CbGpPWpGaD
Cladribine—RRM2—E2F transcription factor network—CDKN2A—Barrett's esophagus	0.000858	0.0112	CbGpPWpGaD
Cladribine—POLE2—Mitotic G1-G1/S phases—CDKN2A—Barrett's esophagus	0.000782	0.0102	CbGpPWpGaD
Cladribine—POLE2—G1 to S cell cycle control—TP53—Barrett's esophagus	0.000753	0.00981	CbGpPWpGaD
Cladribine—PNP—Metabolism—PTGES—Barrett's esophagus	0.000745	0.0097	CbGpPWpGaD
Cladribine—RRM2B—Direct p53 effectors—TP53—Barrett's esophagus	0.000692	0.00901	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—CYP26A1—Barrett's esophagus	0.000651	0.00848	CbGpPWpGaD
Cladribine—POLE2—Retinoblastoma (RB) in Cancer—TP53—Barrett's esophagus	0.000618	0.00805	CbGpPWpGaD
Cladribine—SLC28A3—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000612	0.00798	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000594	0.00774	CbGpPWpGaD
Cladribine—POLA1—E2F transcription factor network—CDKN2A—Barrett's esophagus	0.000587	0.00765	CbGpPWpGaD
Cladribine—PNP—Metabolism—CYP26A1—Barrett's esophagus	0.000565	0.00735	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—NR1I2—Barrett's esophagus	0.00054	0.00703	CbGpPWpGaD
Cladribine—RRM2—Mitotic G1-G1/S phases—CDKN2A—Barrett's esophagus	0.000525	0.00684	CbGpPWpGaD
Cladribine—RRM1—Retinoblastoma (RB) in Cancer—TP53—Barrett's esophagus	0.000504	0.00656	CbGpPWpGaD
Cladribine—POLE—Mitotic G1-G1/S phases—CDKN2A—Barrett's esophagus	0.000504	0.00656	CbGpPWpGaD
Cladribine—POLE—G1 to S cell cycle control—TP53—Barrett's esophagus	0.000485	0.00632	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—SLC9A1—Barrett's esophagus	0.000469	0.00611	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000451	0.00588	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PTGES—Barrett's esophagus	0.000428	0.00557	CbGpPWpGaD
Cladribine—RRM2—Retinoblastoma (RB) in Cancer—TP53—Barrett's esophagus	0.000415	0.00541	CbGpPWpGaD
Cladribine—PNP—Metabolism—SLC9A1—Barrett's esophagus	0.000407	0.0053	CbGpPWpGaD
Cladribine—POLE—Retinoblastoma (RB) in Cancer—TP53—Barrett's esophagus	0.000398	0.00519	CbGpPWpGaD
Cladribine—DCK—Retinoblastoma (RB) in Cancer—TP53—Barrett's esophagus	0.000388	0.00505	CbGpPWpGaD
Cladribine—NR5A1—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.000369	0.0048	CbGpPWpGaD
Cladribine—POLA1—Mitotic G1-G1/S phases—CDKN2A—Barrett's esophagus	0.000359	0.00468	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PTGES—Barrett's esophagus	0.000352	0.00459	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—PPARG—Barrett's esophagus	0.000347	0.00452	CbGpPWpGaD
Cladribine—ABCG2—Fluoropyrimidine Activity—TP53—Barrett's esophagus	0.000337	0.00439	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000335	0.00436	CbGpPWpGaD
Cladribine—DCK—Metabolism—PTGES—Barrett's esophagus	0.000329	0.00429	CbGpPWpGaD
Cladribine—RRM1—Metabolism—CYP26A1—Barrett's esophagus	0.000324	0.00422	CbGpPWpGaD
Cladribine—SLC22A2—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000299	0.0039	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle, Mitotic—CDKN2A—Barrett's esophagus	0.000287	0.00373	CbGpPWpGaD
Cladribine—POLA1—Retinoblastoma (RB) in Cancer—TP53—Barrett's esophagus	0.000284	0.0037	CbGpPWpGaD
Cladribine—NR5A1—Developmental Biology—RELA—Barrett's esophagus	0.000281	0.00366	CbGpPWpGaD
Cladribine—SLC22A1—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	0.000279	0.00363	CbGpPWpGaD
Cladribine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000269	0.0035	CbGpPWpGaD
Cladribine—RRM2—Metabolism—CYP26A1—Barrett's esophagus	0.000267	0.00348	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—CDKN2A—Barrett's esophagus	0.000256	0.00334	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000254	0.00331	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000251	0.00327	CbGpPWpGaD
Cladribine—DCK—Metabolism—CYP26A1—Barrett's esophagus	0.00025	0.00325	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000248	0.00323	CbGpPWpGaD
Cladribine—RRM1—Metabolism—SLC9A1—Barrett's esophagus	0.000234	0.00305	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000231	0.00301	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—PPARG—Barrett's esophagus	0.000214	0.00279	CbGpPWpGaD
Cladribine—RRM2—Metabolism—SLC9A1—Barrett's esophagus	0.000192	0.00251	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle, Mitotic—CDKN2A—Barrett's esophagus	0.000192	0.00251	CbGpPWpGaD
Cladribine—PNP—Metabolism—PPARG—Barrett's esophagus	0.000186	0.00242	CbGpPWpGaD
Cladribine—POLE—Cell Cycle, Mitotic—CDKN2A—Barrett's esophagus	0.000185	0.00241	CbGpPWpGaD
Cladribine—DCK—Metabolism—SLC9A1—Barrett's esophagus	0.00018	0.00234	CbGpPWpGaD
Cladribine—NR5A1—Gene Expression—PPARG—Barrett's esophagus	0.000178	0.00231	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—CDKN2A—Barrett's esophagus	0.000172	0.00224	CbGpPWpGaD
Cladribine—RRM2B—Metabolism—PTGS2—Barrett's esophagus	0.000169	0.0022	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—CDKN2A—Barrett's esophagus	0.000165	0.00215	CbGpPWpGaD
Cladribine—ABCG2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000154	0.002	CbGpPWpGaD
Cladribine—SLC22A2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000152	0.00198	CbGpPWpGaD
Cladribine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000151	0.00197	CbGpPWpGaD
Cladribine—PNP—Metabolism—PTGS2—Barrett's esophagus	0.000146	0.0019	CbGpPWpGaD
Cladribine—POLE2—Cell Cycle—TP53—Barrett's esophagus	0.000143	0.00186	CbGpPWpGaD
Cladribine—SLC22A1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000142	0.00185	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PTGES—Barrett's esophagus	0.000132	0.00172	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle, Mitotic—CDKN2A—Barrett's esophagus	0.000132	0.00171	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PTGES—Barrett's esophagus	0.00013	0.0017	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PTGES—Barrett's esophagus	0.000122	0.00158	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—CDKN2A—Barrett's esophagus	0.000118	0.00153	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PPARG—Barrett's esophagus	0.000107	0.00139	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—CYP26A1—Barrett's esophagus	9.99e-05	0.0013	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—CYP26A1—Barrett's esophagus	9.88e-05	0.00129	CbGpPWpGaD
Cladribine—RRM2—Cell Cycle—TP53—Barrett's esophagus	9.58e-05	0.00125	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—CYP26A1—Barrett's esophagus	9.21e-05	0.0012	CbGpPWpGaD
Cladribine—POLE—Cell Cycle—TP53—Barrett's esophagus	9.19e-05	0.0012	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PPARG—Barrett's esophagus	8.79e-05	0.00114	CbGpPWpGaD
Cladribine—RRM1—Metabolism—PTGS2—Barrett's esophagus	8.39e-05	0.00109	CbGpPWpGaD
Cladribine—DCK—Metabolism—PPARG—Barrett's esophagus	8.21e-05	0.00107	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—SLC9A1—Barrett's esophagus	7.2e-05	0.000938	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—SLC9A1—Barrett's esophagus	7.12e-05	0.000928	CbGpPWpGaD
Cladribine—RRM2—Metabolism—PTGS2—Barrett's esophagus	6.91e-05	0.0009	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—SLC9A1—Barrett's esophagus	6.64e-05	0.000865	CbGpPWpGaD
Cladribine—POLA1—Cell Cycle—TP53—Barrett's esophagus	6.55e-05	0.000853	CbGpPWpGaD
Cladribine—DCK—Metabolism—PTGS2—Barrett's esophagus	6.46e-05	0.000841	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PPARG—Barrett's esophagus	3.29e-05	0.000428	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PPARG—Barrett's esophagus	3.25e-05	0.000424	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PPARG—Barrett's esophagus	3.03e-05	0.000395	CbGpPWpGaD
Cladribine—ABCG2—Metabolism—PTGS2—Barrett's esophagus	2.58e-05	0.000337	CbGpPWpGaD
Cladribine—SLC22A2—Metabolism—PTGS2—Barrett's esophagus	2.56e-05	0.000333	CbGpPWpGaD
Cladribine—SLC22A1—Metabolism—PTGS2—Barrett's esophagus	2.38e-05	0.000311	CbGpPWpGaD
